Stefan Mathias Larson

Sectoral Asset Management Inc (Private Equity) (Sectoral Asset Management) is a private equity subsidiary of Sectoral Asset Management, Inc. founded in 2008 by Michael Sjöström. The firm is headquartered in Montréal, Quebec.

MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada.

Prilenia Therapeutics BV develops and manufactures pharmaceuticals. The company was founded in 2018 and is headquartered in Naarden, the Netherlands.

Sectoral Asset Management Inc (Private Equity) (Sectoral Asset Management) is a private equity subsidiary of Sectoral Asset Management, Inc. founded in 2008 by Michael Sjöström. The firm is headquartered in Montréal, Quebec.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

Sectoral Asset Management Inc (Private Equity) (Sectoral Asset Management) is a private equity subsidiary of Sectoral Asset Management, Inc. founded in 2008 by Michael Sjöström. The firm is headquartered in Montréal, Quebec.

MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

Mosaic Biomedicals SL develops personalized cancer treatments. It is engaged in the realization and development of scientific and technical research projects in the field of oncological and tumor diseases. The company was founded by Joan Seoane, Judit Anido Folgueira and José Baselga on April 19, 2013 and is headquartered in Barcelona, Spain.

Mosaic Biomedicals SL develops personalized cancer treatments. It is engaged in the realization and development of scientific and technical research projects in the field of oncological and tumor diseases. The company was founded by Joan Seoane, Judit Anido Folgueira and José Baselga on April 19, 2013 and is headquartered in Barcelona, Spain.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

Sectoral Asset Management Inc (Private Equity) (Sectoral Asset Management) is a private equity subsidiary of Sectoral Asset Management, Inc. founded in 2008 by Michael Sjöström. The firm is headquartered in Montréal, Quebec.

Apnimed, Inc. operates as a clinical-stage company. It discovers novel pharmaceutical therapies for sleep apnea and related disorders. The company was founded by Lawrence G. Miller and Luigi Taranto Montemurro in 2017 and is headquartered in Cambridge, MA.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

Apnimed, Inc. operates as a clinical-stage company. It discovers novel pharmaceutical therapies for sleep apnea and related disorders. The company was founded by Lawrence G. Miller and Luigi Taranto Montemurro in 2017 and is headquartered in Cambridge, MA.

eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA.

Apnimed, Inc. operates as a clinical-stage company. It discovers novel pharmaceutical therapies for sleep apnea and related disorders. The company was founded by Lawrence G. Miller and Luigi Taranto Montemurro in 2017 and is headquartered in Cambridge, MA.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

Sectoral Asset Management Inc (Private Equity) (Sectoral Asset Management) is a private equity subsidiary of Sectoral Asset Management, Inc. founded in 2008 by Michael Sjöström. The firm is headquartered in Montréal, Quebec.

MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada.

MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada.

Sectoral Asset Management Inc (Private Equity) (Sectoral Asset Management) is a private equity subsidiary of Sectoral Asset Management, Inc. founded in 2008 by Michael Sjöström. The firm is headquartered in Montréal, Quebec.

Prilenia Therapeutics BV develops and manufactures pharmaceuticals. The company was founded in 2018 and is headquartered in Naarden, the Netherlands.

MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

Sectoral Asset Management Inc (Private Equity) (Sectoral Asset Management) is a private equity subsidiary of Sectoral Asset Management, Inc. founded in 2008 by Michael Sjöström. The firm is headquartered in Montréal, Quebec.

Prilenia Therapeutics BV develops and manufactures pharmaceuticals. The company was founded in 2018 and is headquartered in Naarden, the Netherlands.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada.

Prilenia Therapeutics BV develops and manufactures pharmaceuticals. The company was founded in 2018 and is headquartered in Naarden, the Netherlands.

MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

Sectoral Asset Management Inc (Private Equity) (Sectoral Asset Management) is a private equity subsidiary of Sectoral Asset Management, Inc. founded in 2008 by Michael Sjöström. The firm is headquartered in Montréal, Quebec.

Sectoral Asset Management Inc (Private Equity) (Sectoral Asset Management) is a private equity subsidiary of Sectoral Asset Management, Inc. founded in 2008 by Michael Sjöström. The firm is headquartered in Montréal, Quebec.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

Sectoral Asset Management Inc (Private Equity) (Sectoral Asset Management) is a private equity subsidiary of Sectoral Asset Management, Inc. founded in 2008 by Michael Sjöström. The firm is headquartered in Montréal, Quebec.

Sectoral Asset Management Inc (Private Equity) (Sectoral Asset Management) is a private equity subsidiary of Sectoral Asset Management, Inc. founded in 2008 by Michael Sjöström. The firm is headquartered in Montréal, Quebec.

MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada.

MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada.

MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada.

MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada.

MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada.

MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada.

MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada.

MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada.

eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada.

Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada.

MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

Sectoral Asset Management Inc (Private Equity) (Sectoral Asset Management) is a private equity subsidiary of Sectoral Asset Management, Inc. founded in 2008 by Michael Sjöström. The firm is headquartered in Montréal, Quebec.

MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada.

MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada.

MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada.

MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada.

Apnimed, Inc. operates as a clinical-stage company. It discovers novel pharmaceutical therapies for sleep apnea and related disorders. The company was founded by Lawrence G. Miller and Luigi Taranto Montemurro in 2017 and is headquartered in Cambridge, MA.

MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada.

Apnimed, Inc. operates as a clinical-stage company. It discovers novel pharmaceutical therapies for sleep apnea and related disorders. The company was founded by Lawrence G. Miller and Luigi Taranto Montemurro in 2017 and is headquartered in Cambridge, MA.

Prilenia Therapeutics BV develops and manufactures pharmaceuticals. The company was founded in 2018 and is headquartered in Naarden, the Netherlands.

MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada.

MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.